Preventing Loss of Independence Through Exercise (PLIE) in Persons With Dementia (PLIE-VA)
Dementia, Alzheimer's Disease
About this trial
This is an interventional supportive care trial for Dementia focused on measuring dementia, clinical trial, behavioral intervention, exercise, complementary and alternative medicine, cognition, function, quality of life
Eligibility Criteria
Inclusion Criteria:
- 120 dyads of individuals with dementia and their primary caregivers will be enrolled, with a goal of 20 dyads per intervention site.
- Veterans with dementia will be prioritized for enrollment at each site.
- Enrollment will be opened to non-Veterans with dementia at the site if there are not an adequate number of Veterans to fill the group.
- Caregivers are not required to be Veterans, but their participation is necessary because they are providing care to the primary participants, many of whom will be Veterans.
Inclusion criteria, primary participant:
- diagnosis of memory loss or dementia
- mild to moderate severity (defined as Clinical Dementia Rating of 0.5, 1 or 2)
- English language fluency
- attendance or willingness to attend adult day health center at least 2 days/week on days that PLIE will be offered
Inclusion criteria, caregivers:
- Provide care for primary participant
- Able to answer study questionnaires related to participant's functional status, dementia-related behaviors, quality of life and their own burden.
- English language fluency
Exclusion Criteria:
Exclusion criteria, primary participant:
- Plans to change days of attendance during the study period so that participant would no longer be attending on at least 2 PLIE days/week.
- Planning to leave the facility during the study period and not willing to come for PLIE classes at least 2 days/week
- Severe vision or hearing impairment (e.g., unable to see or hear well enough to follow instructions)
- Several physical impairment (e.g., paralysis or hemi-paralysis; wheel-chair or bed bound)
- Severe mental health condition (e.g., uncontrolled depression, PTSD, bipolar disorder)
- Limited life expectancy (e.g., enrolled in or eligible for hospice; metastatic cancer)
- Started dementia medication (cholinesterase inhibitor or memantine) in past 3 months.
- Planning to change dementia medication during the study period
- Current participation in another research study
- Lack of legally authorized representative to provide consent
- Lack of consent/assent to study procedures
Exclusion criteria, caregivers:
- Severe vision or hearing impairment (e.g., unable to see or hear well enough to follow instructions)
- Several physical impairment (e.g., paralysis or hemi-paralysis; wheel-chair or bed bound)
- Severe mental health condition (e.g,. uncontrolled depression, PTSD, bipolar)
- Limited life expectancy (e.g., enrolled in or eligible for hospice; metastatic cancer)
- lack of consent
Sites / Locations
- San Francisco VA Medical Center, San Francisco, CA
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Immediate Start
Delayed Start
The Immediate Start group will participate in the Preventing Loss of Independence through Exercise (PLIE) group movement program for 1 hour, 2-3 days/week, for 4 months. After the intervention has been completed, they will be encouraged to maintain PLIE activities on their own for the next 4 months.
Study participants who are randomized to the Delayed Start control group will be placed on a waitlist and will be encouraged to continue participating in their usual activities at the adult day center or in their community setting for 4 months. After the 4-month waitlist period ends, they will participate in the PLIE program for 1 hour, 2-3 days/week, for 4 months.